Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus.

Nat Rev Gastroenterol Hepatol

Barrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Published: February 2014

Advances are being made in understanding the pathogenesis, treatment outcomes and surveillance of Barrett oesophagus. Central obesity and age at onset of gastro-oesophageal reflux are being recognized as risk factors that have implications for screening. The persistent finding of nondysplastic Barrett oesophagus during surveillance is associated with low risk of malignant progression, whereas dysplastic Barrett oesophagus requires continued surveillance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479384PMC
http://dx.doi.org/10.1038/nrgastro.2013.237DOI Listing

Publication Analysis

Top Keywords

barrett oesophagus
20
surveillance barrett
8
barrett
5
oesophagus 2013
4
2013 risk
4
risk stratification
4
surveillance
4
stratification surveillance
4
oesophagus
4
oesophagus advances
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!